BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 19, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Autologous bone marrow mononuclear cells: Phase II data

Researchers at the hospital and colleagues reported data from the double-blind, U.S. Phase II Late TIME trial in 87 patients with significant left ventricular dysfunction (LVEF <=45%) following PCI showing that intracoronary infusion of autologous BMCs given 2-3 weeks following a myocardial infarction (MI) missed the primary endpoint...

Read the full 219 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >